Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 643954, 7 pages
http://dx.doi.org/10.1155/2013/643954
Review Article

Muscle Wasting in Hemodialysis Patients: New Therapeutic Strategies for Resolving an Old Problem

Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Cheng-Gong Road, Neihu, Taipei 114, Taiwan

Received 15 September 2013; Accepted 28 October 2013

Academic Editors: F. Hinoshita and R. Sakai

Copyright © 2013 Chun-Ting Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. A. Checheriţǎ, F. Turcu, and R. F. Dragomirescu, “Chronic complications in hemodialysis: correlations with primary renal disease,” Romanian Journal of Morphology and Embryology, vol. 51, no. 1, pp. 21–26, 2010. View at Google Scholar · View at Scopus
  2. R. Roubenoff, S. B. Heymsfield, J. J. Kehayias, J. G. Cannon, and I. H. Rosenberg, “Standardization of nomenclature of body composition in weight loss,” The American Journal of Clinical Nutrition, vol. 66, no. 1, pp. 192–196, 1997. View at Google Scholar · View at Scopus
  3. K. Kalantar-Zadeh, G. Block, M. H. Humphreys, and J. D. Kopple, “Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients,” Kidney International, vol. 63, no. 3, pp. 793–808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. W. McIntyre, N. M. Selby, M. Sigrist, L. E. Pearce, T. H. Mercer, and P. F. Naish, “Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2210–2216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. W. E. Mitch and A. L. Goldberg, “Mechanisms of disease: mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway,” The New England Journal of Medicine, vol. 335, no. 25, pp. 1897–1905, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. W. E. Mitch and S. R. Price, “Mechanisms activated by kidney disease and the loss of muscle mass,” American Journal of Kidney Diseases, vol. 38, no. 6, pp. 1337–1342, 2001. View at Google Scholar · View at Scopus
  7. T. A. Ikizler, L. B. Pupim, J. R. Brouillette et al., “Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 282, no. 1, pp. E107–E116, 2002. View at Google Scholar · View at Scopus
  8. T. W. Biruh and E. M. William, “Review of muscle wasting associated with chronic kidney disease,” American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1128–1132, 2010. View at Google Scholar
  9. R. W. Jackman and S. C. Kandarian, “The molecular basis of skeletal muscle atrophy,” American Journal of Physiology—Cell Physiology, vol. 287, no. 4, pp. C834–C843, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Shringarpure, T. Grune, J. Mehlhase, and K. J. A. Davies, “Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome,” The Journal of Biological Chemistry, vol. 278, no. 1, pp. 311–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Lecker, A. L. Goldberg, and W. E. Mitch, “Protein degradation by the ubiquitin-proteasome pathway in normal and disease states,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1807–1819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sandri, C. Sandri, A. Gilbert et al., “Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy,” Cell, vol. 117, no. 3, pp. 399–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. T. Workeneh, H. Rondon-Berrios, L. Zhang et al., “Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3233–3239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Du, X. Wang, C. Miereles et al., “Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions,” The Journal of Clinical Investigation, vol. 113, no. 1, pp. 115–123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. T. N. Stitt, D. Drujan, B. A. Clarke et al., “The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors,” Molecular Cell, vol. 14, no. 3, pp. 395–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Chauveau, C. Combe, M. Laville et al., “Factors influencing survival in hemodialysis patients aged older than 75 years: 2.5-year outcome study,” American Journal of Kidney Diseases, vol. 37, no. 5, pp. 997–1003, 2001. View at Google Scholar · View at Scopus
  17. T. L. Kelly, N. Berger, and T. L. Richardson, “DXA body composition: theory and practice,” Applied Radiation and Isotopes, vol. 49, no. 5-6, pp. 511–513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. E. D. Siew, L. B. Pupim, K. M. Majchrzak, A. Shintani, P. J. Flakoll, and T. A. Ikizler, “Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients,” Kidney International, vol. 71, no. 2, pp. 146–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Gao, A. Zuberi, M. J. Quon, Z. Dong, and J. Ye, “Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factortreated cells through targeting multiple serine kinases,” The Journal of Biological Chemistry, vol. 278, no. 27, pp. 24944–24950, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Li, S. H. Lecker, Y. Chen, I. D. Waddell, A. L. Goldberg, and M. B. Reid, “TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k,” The FASEB Journal, vol. 17, no. 9, pp. 1048–1057, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Raff and H. Trivedi, “Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease,” Endocrine Connections, vol. 2, no. 1, pp. 23–31, 2012. View at Google Scholar
  22. Z. Hu, H. Wang, I. H. Lee et al., “Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice,” The Journal of Clinical Investigation, vol. 119, no. 10, pp. 3059–3069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Bailey, B. Zheng, Z. Hu, S. R. Price, and W. E. Mitch, “Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy,” Journal of the American Society of Nephrology, vol. 17, no. 5, pp. 1388–1394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. R. Price, B. K. England, J. L. Bailey, K. Van Vreede, and W. E. Mitch, “Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle,” American Journal of Physiology—Cell Physiology, vol. 267, no. 4, pp. C955–C960, 1994. View at Google Scholar · View at Scopus
  25. W. E. Mitch, R. Medina, S. Grieber et al., “Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes,” The Journal of Clinical Investigation, vol. 93, no. 5, pp. 2127–2133, 1994. View at Google Scholar · View at Scopus
  26. H. A. Franch, S. Raissi, X. Wang, B. Zheng, J. L. Bailey, and S. R. Price, “Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis,” American Journal of Physiology—Renal Physiology, vol. 287, no. 4, pp. F700–F706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. R. Price, J. L. Bailey, X. Wang et al., “Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription,” The Journal of Clinical Investigation, vol. 98, no. 8, pp. 1703–1708, 1996. View at Google Scholar · View at Scopus
  28. M. Brüngger, H. N. Hulter, and R. Krapf, “Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans,” Kidney International, vol. 51, no. 1, pp. 216–221, 1997. View at Google Scholar · View at Scopus
  29. N. Kuemmerle, J. Krieg R.J., K. Latta, A. Challa, J. D. Hanna, and J. C. M. Chan, “Growth hormone and insulin-like growth factor in non-uremic acidosis and uremic acidosis,” Kidney International, Supplement, vol. 58, no. 58, pp. S-102–S-105, 1997. View at Google Scholar · View at Scopus
  30. D. F. Sun, Y. Chen, and R. Rabkin, “Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia,” Kidney International, vol. 70, no. 3, pp. 453–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. Carrero, A. R. Qureshi, P. Parini et al., “Low serum testosterone increases mortality risk among male dialysis patients,” Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 613–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Gungor, F. Kircelli, J. J. Carrero et al., “Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?” Clinical Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 2018–2023, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Gianola, V. Pecoraro, S. Lambiase et al., “Efficacy of muscle exercise in patients with muscular dystrophy: a systematic review showing a missed opportunity to improve outcomes,” PLoS ONE, vol. 8, no. 6, Article ID 65414, 2013. View at Google Scholar
  34. K. L. Johansen, “Exercise and dialysis,” Hemodialysis International, vol. 12, no. 3, pp. 290–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. E. Nelson, W. J. Rejeski, S. N. Blair et al., “Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association,” Circulation, vol. 116, no. 9, pp. 1094–1105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Konstantinidou, G. Koukouvou, E. Kouidi, A. Deligiannis, and A. Tourkantonis, “Exercise training in patients with end-stage renal disease on hemodialysis: comparison of three rehabilitation programs,” Journal of Rehabilitation Medicine, vol. 34, no. 1, pp. 40–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Deligiannis, E. Kouidi, E. Tassoulas, P. Gigis, A. Tourkantonis, and A. Coats, “Cardiac effects of exercise rehabilitation in hemodialysis patients,” International Journal of Cardiology, vol. 70, no. 3, pp. 253–266, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. J. E. Anderson, M. R. Boivin Jr., and L. Hatchett, “Effect of exercise training on interdialytic ambulatory and treatment-related blood pressure in hemodialysis patients,” Renal Failure, vol. 26, no. 5, pp. 539–544, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. B. W. Miller, C. L. Cress, M. E. Johnson, D. H. Nichols, and M. A. Schnitzler, “Exercise during hemodialysis decreases the use of antihypertensive medications,” American Journal of Kidney Diseases, vol. 39, no. 4, pp. 828–833, 2002. View at Google Scholar · View at Scopus
  40. A. P. Goldberg, E. M. Geltman, and J. R. Gavin III, “Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients,” Nephron, vol. 42, no. 4, pp. 311–316, 1986. View at Google Scholar · View at Scopus
  41. S. Frey, A. R. Mir, and M. Lucas, “Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease,” Journal of Renal Nutrition, vol. 9, no. 2, pp. 71–77, 1999. View at Google Scholar · View at Scopus
  42. E. Kouidi, M. Albani, K. Natsis et al., “The effects of exercise training on muscle atrophy in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 13, no. 3, pp. 685–699, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Castaneda, P. L. Gordon, R. C. Parker, K. L. Uhlin, R. Roubenoff, and A. S. Levey, “Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease,” American Journal of Kidney Diseases, vol. 43, no. 4, pp. 607–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. R. J. Mullan, V. M. Montori, N. D. Shah et al., “The diabetes mellitus medication choice decision aid: a randomized trial,” Archives of Internal Medicine, vol. 169, no. 17, pp. 1560–1568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Wang, Z. Hu, J. Hu, J. Du, and W. E. Mitch, “Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling,” Endocrinology, vol. 147, no. 9, pp. 4160–4168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. B. Pupim, O. Heimbürger, A. R. Qureshi, T. A. Ikizler, and P. Stenvinkel, “Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus,” Kidney International, vol. 68, no. 5, pp. 2368–2374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Simon, “Thiazolidinediones/insulin use and cancer risk: insights from the recent meta-analyses,” Diabetes and Metabolism, vol. 39, no. 1, pp. 3–5, 2013. View at Google Scholar
  48. K. Kalantar-Zadeh, R. Mehrotra, D. Fouque, and J. D. Kopple, “Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure,” Seminars in Dialysis, vol. 17, no. 6, pp. 455–465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. K. A. Graham, D. Reaich, S. M. Channon, S. Downie, and T. H. J. Goodship, “Correction of acidosis in hemodialysis decreases whole-body protein degradation,” Journal of the American Society of Nephrology, vol. 8, no. 4, pp. 632–637, 1997. View at Google Scholar · View at Scopus
  50. M. R. Wiederkehr, J. Kalogiros, and R. Krapf, “Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 19, no. 5, pp. 1190–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Kalhoff, L. Diekmann, C. Kunz, G. J. Stock, and F. Manz, “Alkali therapy versus sodium chloride supplement in low birthweight infants with incipient late metabolic acidosis,” Acta Paediatrica, vol. 86, no. 1, pp. 96–101, 1997. View at Google Scholar · View at Scopus
  52. Y. Boirie, M. Broyer, M. F. Gagnadoux, P. Niaudet, and J. Bresson, “Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure,” Kidney International, vol. 58, no. 1, pp. 236–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. J. E. Morley, H. M. Perry III, F. E. Kaiser et al., “Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study,” Journal of the American Geriatrics Society, vol. 41, no. 2, pp. 149–152, 1993. View at Google Scholar · View at Scopus
  54. R. Sih, J. E. Morley, F. E. Kaiser, H. M. Perry III, P. Patrick, and C. Ross, “Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, pp. 1661–1667, 1997. View at Google Scholar · View at Scopus
  55. K. L. Johansen, P. L. Painter, G. K. Sakkas, P. Gordon, J. Doyle, and T. Shubert, “Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2307–2314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. J. H. MacDonald, S. M. Marcora, M. M. Jibani, M. J. Kumwenda, W. Ahmed, and A. B. Lemmey, “Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study,” Nephron, vol. 106, no. 3, pp. c125–c135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. W. E. Mitch, “Malnutrition: a frequent misdiagnosis for hemodialysis patients,” The Journal of Clinical Investigation, vol. 110, no. 4, pp. 437–439, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Kalantar-Zadeh, G. Block, C. J. McAllister, M. H. Humphreys, and J. D. Kopple, “Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients,” American Journal of Clinical Nutrition, vol. 80, no. 2, pp. 299–307, 2004. View at Google Scholar · View at Scopus
  59. M. Berger, J. White, and L. B. Travis, “Toxic psychosis due to cyproheptadine in a child on hemodialysis: a case report,” Clinical Nephrology, vol. 7, no. 1, pp. 43–44, 1977. View at Google Scholar · View at Scopus
  60. J. Gołebiewska, M. Lichodziejewska-Niemierko, E. Aleksandrowicz, M. Majkowicz, W. Łysiak-Szydłowska, and B. Rutkowski, “Influence of megestrol acetate on nutrition and inflammation in dialysis patients: preliminary results,” Acta Biochimica Polonica, vol. 56, no. 4, pp. 733–737, 2009. View at Google Scholar · View at Scopus
  61. J. A. Boccanfuso, M. Hutton, and B. McAllister, “The effects of megestrol acetate on nutritional parameters in a dialysis population,” Journal of Renal Nutrition, vol. 10, no. 1, pp. 36–43, 2000. View at Google Scholar · View at Scopus
  62. R. J. Stratton, G. Bircher, D. Fouque et al., “Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis,” American Journal of Kidney Diseases, vol. 46, no. 3, pp. 387–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. N. J. M. Cano, D. Fouque, H. Roth et al., “Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2583–2591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. L. B. Pupim, P. J. Flakoll, J. R. Brouillette, D. K. Levenhagen, R. M. Hakim, and T. A. Ikizler, “Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients,” The Journal of Clinical Investigation, vol. 110, no. 4, pp. 483–492, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. L. B. Pupim, K. M. Majchrzak, P. J. Flakoll, and T. A. Ikizler, “Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3149–3157, 2006. View at Publisher · View at Google Scholar · View at Scopus